☆ 4.6 Review

Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis

FRONTIERS IN AGING NEUROSCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Geriatrics & Gerontology

Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition

Mary Sano et al.

Summary: This study evaluates the consensus-based definition of agitation by the International Psycho-geriatric Association (IPA) in a community-based sample. The results show that there is agreement between the selected measurement method and clinician judgment of agitation, and a significant proportion of individuals with agitation, as judged by clinicians or based on a scale, demonstrate excess social/functional disability.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2022)

Add to Collection

Review Health Policy & Services

Cost-effectiveness of pharmacological therapies for people with Alzheimer's disease and other dementias: a systematic review and meta-analysis

Zhaohua Huo et al.

Summary: This study synthesized empirical economic evidence on pharmaceutical therapies for people with dementia, finding that AChEIs and memantine are cost-effective treatments with improvements in dementia-related symptoms and trends of cost savings. However, antidepressants and second-generation antipsychotics were limited by their significant side effects on patients' cognitive and activity functions. More empirical evidence with non-industrial sponsorships and rigorous design in different settings is warranted.

COST EFFECTIVENESS AND RESOURCE ALLOCATION (2022)

Add to Collection

Review Pharmacology & Pharmacy

A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD)

Haider Saddam Qasim et al.

Summary: This review evaluates the pharmacological interventions for psychomotor agitation in aged care facilities. The findings suggest that selective serotonin reuptake inhibitors (SSRIs) such as citalopram are effective in reducing agitation symptoms and have a lower risk of adverse effects compared to antipsychotics. However, there is still a limited amount of research on SSRIs for agitation in BPSD, and further studies are needed to assess their long-term safety and efficacy.

PHARMACY (2022)

Add to Collection

Article Geriatrics & Gerontology

Exploring carer resilience in the context of dementia: a meta-synthesis

Eun Young Kim et al.

Summary: This study aims to integrate the results of qualitative research on the resilience experiences of family carers of people with dementia. Through a qualitative meta-synthesis approach, the study identified three themes that illustrate how family carers overcome adversities, including perceiving caregiving as one's duty, setting boundaries in life, and moving forward towards personal development.

BMC GERIATRICS (2022)

Add to Collection

Article Psychiatry

The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia

Anderson Chen et al.

Summary: This article updates algorithms for the use of psychopharmacologic agents in geriatric patients with dementia, proposing different treatment approaches for emergent, urgent, and non-urgent settings. Recommendations for specific medications like olanzapine and trazodone are provided based on the severity of the situation.

PSYCHIATRY RESEARCH (2021)

Add to Collection

Article Geriatrics & Gerontology

Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience

Matteo Cotta Ramusino et al.

Summary: The study investigated the distribution of behavioral and psychological symptoms in patients with cognitive impairment, identifying a higher prevalence of psychotic symptoms in LBD patients. Furthermore, the study found associations between CSF tau levels, frontal atrophy, and the severity of BPSD.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection

Review Cell Biology

Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: A systematic review and meta-analysis

Tien-Wei Hsu et al.

Summary: This meta-analysis demonstrates that serotonergic antidepressants effectively alleviate overall neuropsychiatric symptoms, agitation, depressive symptoms, and care burden in patients with dementia, as well as improving cognitive function.

AGEING RESEARCH REVIEWS (2021)

Add to Collection

Review Pharmacology & Pharmacy

The effects of trazodone on human cognition: a systematic review

Ana Mafalda Goncalves Goncalo et al.

Summary: Trazodone, a widely used antidepressant, has been found to have a new mechanism of action on the unfolded protein response pathway, showing potential benefits in slowing neurodegenerative progression. Studies on its effects on human cognition have shown conflicting results, with some indicating improvement, while others showed impaired cognitive function. Further research is needed to explore its impact on neurodegenerative diseases in humans.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Add to Collection

Review Clinical Neurology

Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates

Monika Marcinkowska et al.

CNS DRUGS (2020)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress

Radoslaw Magierski et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Article Clinical Neurology

Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease

Athanasios Metaxas et al.

ALZHEIMERS RESEARCH & THERAPY (2019)

Add to Collection

Article Clinical Neurology

Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial

Stephan Ehrhardt et al.

ALZHEIMERS & DEMENTIA (2019)

Add to Collection

Article Medicine, Research & Experimental

Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer's disease: A clinical trial

Tiantian Zhou et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)

Add to Collection

Article Psychology, Clinical

Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis

Myuri Ruthirakuhan et al.

JOURNAL OF CLINICAL PSYCHIATRY (2019)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis

Khachen Kongpakwattana et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Add to Collection

Article Psychology, Clinical

High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death

Wayne A. Ray et al.

JOURNAL OF CLINICAL PSYCHIATRY (2017)

Add to Collection

Article Medicine, General & Internal

Delirium Day: a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool

Giuseppe Bellelli et al.

BMC MEDICINE (2016)

Add to Collection

Article Pharmacology & Pharmacy

R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation

Thang Ho et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Add to Collection

Article Pharmacology & Pharmacy

Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses

Rajesh R. Tampi et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2016)

Add to Collection

Article Medicine, General & Internal

Effect of Citalopram on Agitation in Alzheimer Disease The CitAD Randomized Clinical Trial

Anton P. Porsteinsson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Add to Collection

Article Psychiatry

Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg

Kara Zivin et al.

AMERICAN JOURNAL OF PSYCHIATRY (2013)

Add to Collection

Article Medicine, General & Internal

QT interval and antidepressant use: a cross sectional study of electronic health records

Victor M. Castro et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Add to Collection

Article Multidisciplinary Sciences

Efficacy of Memantine for Agitation in Alzheimer's Dementia: A Randomised Double-Blind Placebo Controlled Trial

Chris Fox et al.

PLOS ONE (2012)

Add to Collection

Article Geriatrics & Gerontology

A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer's Disease

Alistair Burns et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)

Add to Collection

Review Medicine, General & Internal

Antidepressants for agitation and psychosis in dementia

D. P. Seitz et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)

Add to Collection

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Add to Collection

Article Medicine, General & Internal

Donepezil for the treatment of agitation in Alzheimer's disease

Robert J. Howard et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Add to Collection

Article Geriatrics & Gerontology

Frontotemporal dementia: A randomised, controlled trial with trazodone

F Lebert et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)

Add to Collection

Article Geriatrics & Gerontology

A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil

SI Finkel et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)

Add to Collection

Article Geriatrics & Gerontology

No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients

MF Weiner et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2002)

Add to Collection

Article Geriatrics & Gerontology

Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease

KL Lanctôt et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2002)

Add to Collection

Article Psychiatry

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

BG Pollock et al.

AMERICAN JOURNAL OF PSYCHIATRY (2002)

Add to Collection

Article Geriatrics & Gerontology

A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease

C Magai et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2000)

Add to Collection

Article Clinical Neurology

Treatment of agitation in AD - A randomized, placebo-controlled clinical trial

L Teri et al.

NEUROLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.